In last trading session, Tevogen Bio Holdings Inc (NASDAQ:TVGN) saw 1.41 million shares changing hands with its beta currently measuring -1.13. Company’s recent per share price level of $1.34 trading at -$0.11 or -7.59% at ring of the bell on the day assigns it a market valuation of $234.56M. That closing price of TVGN’s stock is at a discount of -1473.88% from its 52-week high price of $21.09 and is indicating a premium of 80.6% from its 52-week low price of $0.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 7.94 million shares which gives us an average trading volume of 3.70 million if we extend that period to 3-months.

Tevogen Bio Holdings Inc (NASDAQ:TVGN) trade information

Upright in the red during last session for losing -7.59%, in the last five days TVGN remained trading in the red while hitting it’s week-highest on Monday, 01/27/25 when the stock touched $1.34 price level, adding 30.21% to its value on the day. Tevogen Bio Holdings Inc’s shares saw a change of 30.10% in year-to-date performance and have moved -2.90% in past 5-day. Tevogen Bio Holdings Inc (NASDAQ:TVGN) showed a performance of 30.10% in past 30-days. Number of shares sold short was 3.69 million shares which calculate 0.09 days to cover the short interests.

On the other hand, Fidelity Small Cap Index Fund and iShares Russell 2000 Growth ETF are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 226.32 shares of worth $0.3 million or 0.13% of the total outstanding shares. The later fund manager was in possession of 147.28 shares on Nov 30, 2024 , making its stake of worth around $0.2 million in the company or a holder of 0.08% of company’s stock.